YUFLYMA

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
YUFLYMA

ACTIVE PRINCIPLE
ADALIMUMAB

TYPE OF DEVICE
PRE-FILLED PEN

LATEX
DO NOT

TEMPERING TIME
60 -70 minutes

START OF INJECTION
Pressing against the skin

CLICK TO THE START (IN PEN)
YES

CLICK AT THE END (IN PEN)
YES